BioPlant, a dental bone grafting material. BioPlant has been assigned the product code LYC (Bone Grafting Material, Synthetic) by the FDA and is classified as a Class II Medical Device. BioPlant is a Class II Medical Device. The Device Listing Number is 0007254. BioPlant is a synthetic, multipurpose bone-grafting material intended to be used in dental applications to maintain and restore the bony alveolar ridge in post-extraction tooth-root sockets or after oral surgery, ridge preservation, ridge augmentation, augmentations in the maxillary sinus, repair of periodontal defects and bone voids associated with dental implant placement.
Published November 28, 2012 · Recall initiated: October 25, 2012
Summary
FDA records medical device Class II recall Z-0401-2013, published November 28, 2012 and initiated October 25, 2012. Recalling firm: Kerr Corporation; Status: Terminated; Reported quantity: 22,410 units; Lot: The BioPlant part numbers and lot numbers affected by this recall are as follows: Product Description Part Numbers Lot Numbers BioPlant Curved Syringe, 0.125g 216110 All Production BioPlant Curved Syringe, 0.25g 216112 BioPlant Curved Svrinoe, 0.50<1 216114 Lots Within Shelf-Life BioPlant Curved Svrinoe, 0.250 216132 20k BioPlant Intro Pack 216112S. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The firm initiated the recall becaue disturbing the BioPlant product soon after it is placed may halt or delay the ossification process.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Kerr Corporation
- Distributor
- Worldwide Distribution - USA (nationwide) Canada, Europe, Australia and ROW consignees .
- Lot
- The BioPlant part numbers and lot numbers affected by this recall are as follows: Product Description Part Numbers Lot Numbers BioPlant Curved Syringe, 0.125g 216110 All Production BioPlant Curved Syringe, 0.25g 216112 BioPlant Curved Svrinoe, 0.50<1 216114 Lots Within Shelf-Life BioPlant Curved Svrinoe, 0.250 216132 20k BioPlant Intro Pack 216112S
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDATytin Regular Set, Double Spill, 50 Capsules, Part Number 29948, Lot Number 3-1294. The intended use of thisJune 25, 2014
- FDAFreedom Cordless LED Light System. Freedom System, Standard Length, Part Number 910863-1, Serial NumbersNovember 28, 2012
- FDAThe brand name of the device is Laser Loupes, a dentalloupe with laser eye protection. Laser Loupes have beenNovember 28, 2012
- FDA00780304001 MIS 12/14 Slotted Femoral Head Provisional -3.5X36 00780304002 MIS 12/14 Slotted Femoral HeadNovember 28, 2012
- FDA00780303601 MIS 12/14 Slotted Femoral Head Provisional -3.5X36 00780303602 MIS 12/14 Slotted Femoral HeadNovember 28, 2012
- FDAThe brand name of the device is AlgiNot, a dental impression material. Product Part Numbers AlgiNot Intra KitNovember 14, 2012
Questions about this recall
Was BioPlant, a dental bone grafting material. BioPlant has been assigned the product code LYC (Bone Grafting Material, Synthetic) by the FDA and is classified as a Class II Medical Device. BioPlant is a Class II Medical Device. The Device Listing Number is 0007254. BioPlant is a synthetic, multipurpose bone-grafting material intended to be used in dental applications to maintain and restore the bony alveolar ridge in post-extraction tooth-root sockets or after oral surgery, ridge preservation, ridge augmentation, augmentations in the maxillary sinus, repair of periodontal defects and bone voids associated with dental implant placement. recalled?
Yes. FDA published recall Z-0401-2013 on November 28, 2012. Reported hazard: The firm initiated the recall becaue disturbing the BioPlant product soon after it is placed may halt or delay the ossification process.
What should I do if I have this product?
Voluntary: Firm initiated · Letter